Article Details
Retrieved on: 2018-03-21 20:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Momenta Pharmaceuticals logo <b>BlackRock Inc</b>. raised its position in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) by 0.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,473,316 shares of the biotechnology ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here